Literature DB >> 29458724

The Evolving Spectrum of the Epidemiology of Thalassemia.

David J Weatherall1.   

Abstract

The thalassemias and other inherited disorders of hemoglobin are likely to remain a serious global health problem for the foreseeable future. Currently, they are most frequent in the tropical belt; an assessment of their true frequency and the likely cost of management for the governments of these countries will require a form of micromapping. Over recent years, there has been major progress toward better prevention and management of the thalassemias in richer countries; it is likely that, using the tools of molecular genetics, they will eventually be completely curable, although this is probably a long time in the future. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Future control; Future frequency; Global frequency; Malaria; North/South partnerships; Thalassemia

Mesh:

Substances:

Year:  2018        PMID: 29458724     DOI: 10.1016/j.hoc.2017.11.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  22 in total

Review 1.  [Skeletal manifestations of systemic hematologic disorders].

Authors:  J Luitjens; A Baur-Melnyk
Journal:  Radiologe       Date:  2021-11-24       Impact factor: 0.635

2.  Prenatal diagnosis of thalassemia in 695 pedigrees from southeastern China: a 10-year follow-up study.

Authors:  Hailong Huang; Meihuan Chen; Lingji Chen; Min Zhang; Yan Wang; Na Lin; Liangpu Xu
Journal:  J Clin Lab Anal       Date:  2021-09-04       Impact factor: 2.352

3.  Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand.

Authors:  Nattiya Teawtrakul; Duantida Songdej; Chattree Hantaweepant; Adisak Tantiworawit; Supanun Lauhasurayotin; Kitti Torcharus; Pornpun Sripornsawan; Pranee Sutcharitchan; Pacharapan Surapolchai; Patcharee Komvilaisak; Supawee Saengboon; Bunchoo Pongtanakul; Pimlak Charoenkwan
Journal:  Transfusion       Date:  2022-08-20       Impact factor: 3.337

4.  ZNF410 represses fetal globin by singular control of CHD4.

Authors:  Divya S Vinjamur; Qiuming Yao; Mitchel A Cole; Connor McGuckin; Chunyan Ren; Jing Zeng; Mir Hossain; Kevin Luk; Scot A Wolfe; Luca Pinello; Daniel E Bauer
Journal:  Nat Genet       Date:  2021-04-15       Impact factor: 38.330

5.  Hematological and biochemical evaluation of β-thalassemia major (βTM) patients in Gaza Strip: A cross-sectional study.

Authors:  Hani Ayyash; Mahmoud Sirdah
Journal:  Int J Health Sci (Qassim)       Date:  2018 Nov-Dec

6.  Oocyte quality in women with thalassaemia major: insights from IVF cycles.

Authors:  Laura Mensi; Raffaella Borroni; Marco Reschini; Elena Cassinerio; Walter Vegetti; Marina Baldini; Maria Domenica Cappellini; Edgardo Somigliana
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-13

Review 7.  Genome-based therapeutic interventions for β-type hemoglobinopathies.

Authors:  Kariofyllis Karamperis; Maria T Tsoumpeli; Fotios Kounelis; Maria Koromina; Christina Mitropoulou; Catia Moutinho; George P Patrinos
Journal:  Hum Genomics       Date:  2021-06-05       Impact factor: 4.639

Review 8.  Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.

Authors:  Dito Anurogo; Nova Yuli Prasetyo Budi; Mai-Huong Thi Ngo; Yen-Hua Huang; Jeanne Adiwinata Pawitan
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

9.  Rare Presentation of Right Adrenal Mass: Extramedullary Haematopoiesis in a Patient with Thalassaemia Intermedia.

Authors:  Poh Shean Wong; Lit Sin Yong; Nor Afidah Binti Karim; Ee Leng Gan; See Guan Toh; Noor Lita Binti Adam
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-04-17

10.  Clinical utility of combined preimplantation genetic testing methods in couples at risk of passing on beta thalassemia/hemoglobin E disease: A retrospective review from a single center.

Authors:  Chonthicha Satirapod; Matchuporn Sukprasert; Bhakbhoom Panthan; Angkana Charoenyingwattana; Pawares Chitayanan; Wasun Chantratita; Wicharn Choktanasiri; Objoon Trachoo; Suradej Hongeng
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.